Resources
- sort by:
- Relevance
- Date
- Popularity
- GlaxoSmithKline to purchase ID Biomedical and CytRx says preliminary data show encouraging potential for HIV vaccine.
- M2 PRESSWIRE-8 September 2005-US Financial Network: GlaxoSmithKline to purchase ID Biomedical and CytRx says preliminary data show encouraging potential for HIV vaccineC1994-2005 M2 COMMUNICATIONS LTD RDATE:08092005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU)...
- Research articles 2005-09-08
- Id Biomedical Announces Private Placement
- VANCOUVER, British Columbia--BUSINESS WIRE--Dec. 15, 1994--ID Biomedical Corp. IDB announced today that it has signed a letter of intent and filed notice with The Montreal Exchange and Vancouver Stock Exchange for a US$1,000,000 private placement of Special Warrants with a single institutional investor. The Special Warrants will...
- Research articles 1994-12-15
- Spire Corp files 1.5 million share offer
- US company Spire Corp, which provides products and services to the optoelectronics, photovoltaics and biomedical markets worldwide, has announced that it has filed a registration statement with the US Securities and Exchange Commission for a proposed uUS company Spire Corp, which provides products and services to the...
- Research articles 1998-02-01
- Viasys spun off.(Thermo Electron Corp., Viasys Healthcare Inc.)(Brief Article)
- CONSHOHOCKEN, PENNSYLVANIA--Thermo Electron Corp. has spun off its biomedical manufacturing business into an independent, publicly traded company called Viasys Healthcare Inc. The new company includes three divisions-Medical/Surgical Products, Respiratory Care and Neurocare. It runs 10 manufacturing facilities across the US, comprising about 38000[m.sup.2],...
- Research articles 2002-02-01
- Cambridge, Mass., Biomedical Firm Focuses on Managing Dialysis-Drug Inventory.
- By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News Mar. 28--Genzyme Corp. yesterday said it is taking aggressive steps to manage inventory of its dialysis drug, Renagel, among US wholesalers, forcing the Cambridge company to cut sales projections by almost half for the...
- Research articles 2002-03-28
- Idb Completes Private Placement Financing And Acquisition Of All Minority Id Vaccine Shares
- VANCOUVER, British Columbia--BUSINESS WIRE--Jan. 17, 1995--ID Biomedical Corp. IDB announced today that it has completed its previously announced Special Warrants private placement for US$1,000,000.The total number of Special Warrants issued under this private placement was 134,116 and they are exchangeable into common shares of IDB on a one for one...
- Research articles 1995-01-17
- INDUSTRY NEWS: Integra and LifeCell settle their differences
- Two US companies involved in the development of biomaterials particularly for use in the treatment of burns and skin defects said they have resolved their differences and that all litigation pending between them is now settled. (See Biomedical Materials, December 1997, pp. 5-6.)LifeCell Corp, based in Texas, and Integra LifeSciences...
- Research articles 1998-06-01
- Market Pulse Breaking News Alert for Monday, May 9, 2005: BIPH - Biophan Files SEC Form 8K/A Regarding Acquisitions of MRI Biotechnology Companies aMRIs and MR Comp!
- Market Pulse News Alert for this AM, Stocks to Watch are: Biophan Technologies, Inc. (OTC BB: BIPH), Intel Corp. (NASDAQ: INTC), Sirius Satellite Radio Inc. (NASDAQ: SIRI), and Siebel Systems Inc. (NASDAQ: SEBL). Investors need to be watching Biophan Technologies, Inc. (OTC BB: BIPH) this AM! Biophan develops and...
- Research articles 2005-05-09
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
